OBJECTIVES: This study describes the microbiological spectrum of chronic osteomyelitis and so guides the choice of empirical antibiotics for this condition. METHODS: We performed a prospective review of a 166 prospective patient series of chronic osteomyelitis from Oxford, UK in which a standardised surgical sampling protocol was used. RESULTS: Staphylococcus aureus was most commonly isolated (32%) amongst a wide range of organisms including gram negative bacilli, anaerobes and coagulase negative staphylococci. Low grade pathogens were not confined to patients with a history of metalwork, a high proportion of cases were polymicrobial (29%) and culture negative cases were common (28%). No clear predictors of causative organism could be established. Many isolates were found to be resistant to commonly used empirical anti-microbial regimens. CONCLUSIONS: The wide range of causative organisms and degree of resistance to commonly used anti-microbials supports the importance of extensive intra-operative sampling and provides important information to guide clinicians' choice of empirical antibiotics. Crown Copyright 2010. Published by Elsevier Ltd. All rights reserved.
OBJECTIVES: This study describes the microbiological spectrum of chronic osteomyelitis and so guides the choice of empirical antibiotics for this condition. METHODS: We performed a prospective review of a 166 prospective patient series of chronic osteomyelitis from Oxford, UK in which a standardised surgical sampling protocol was used. RESULTS:Staphylococcus aureus was most commonly isolated (32%) amongst a wide range of organisms including gram negative bacilli, anaerobes and coagulase negative staphylococci. Low grade pathogens were not confined to patients with a history of metalwork, a high proportion of cases were polymicrobial (29%) and culture negative cases were common (28%). No clear predictors of causative organism could be established. Many isolates were found to be resistant to commonly used empirical anti-microbial regimens. CONCLUSIONS: The wide range of causative organisms and degree of resistance to commonly used anti-microbials supports the importance of extensive intra-operative sampling and provides important information to guide clinicians' choice of empirical antibiotics. Crown Copyright 2010. Published by Elsevier Ltd. All rights reserved.
Authors: Ho-Kwong Li; Ines Rombach; Rhea Zambellas; A Sarah Walker; Martin A McNally; Bridget L Atkins; Benjamin A Lipsky; Harriet C Hughes; Deepa Bose; Michelle Kümin; Claire Scarborough; Philippa C Matthews; Andrew J Brent; Jose Lomas; Roger Gundle; Mark Rogers; Adrian Taylor; Brian Angus; Ivor Byren; Anthony R Berendt; Simon Warren; Fiona E Fitzgerald; Damien J F Mack; Susan Hopkins; Jonathan Folb; Helen E Reynolds; Elinor Moore; Jocelyn Marshall; Neil Jenkins; Christopher E Moran; Andrew F Woodhouse; Samantha Stafford; R Andrew Seaton; Claire Vallance; Carolyn J Hemsley; Karen Bisnauthsing; Jonathan A T Sandoe; Ila Aggarwal; Simon C Ellis; Deborah J Bunn; Rebecca K Sutherland; Gavin Barlow; Cushla Cooper; Claudia Geue; Nicola McMeekin; Andrew H Briggs; Parham Sendi; Elham Khatamzas; Tri Wangrangsimakul; T H Nicholas Wong; Lucinda K Barrett; Abtin Alvand; C Fraser Old; Jennifer Bostock; John Paul; Graham Cooke; Guy E Thwaites; Philip Bejon; Matthew Scarborough Journal: N Engl J Med Date: 2019-01-31 Impact factor: 91.245
Authors: Steven Y C Tong; Joshua S Davis; Emily Eichenberger; Thomas L Holland; Vance G Fowler Journal: Clin Microbiol Rev Date: 2015-07 Impact factor: 26.132
Authors: James K-K Chan; Alexander L Aquilina; Sharon R Lewis; Jeremy N Rodrigues; Xavier L Griffin; Jagdeep Nanchahal Journal: Cochrane Database Syst Rev Date: 2022-04-01
Authors: Christina Ziegler; Oliver Goldmann; Elias Hobeika; Robert Geffers; Georg Peters; Eva Medina Journal: EMBO Mol Med Date: 2011-09-02 Impact factor: 12.137
Authors: Lorena Tuchscherr; Eva Medina; Muzaffar Hussain; Wolfgang Völker; Vanessa Heitmann; Silke Niemann; Dirk Holzinger; Johannes Roth; Richard A Proctor; Karsten Becker; Georg Peters; Bettina Löffler Journal: EMBO Mol Med Date: 2011-01-26 Impact factor: 12.137
Authors: Ho Kwong Li; Matthew Scarborough; Rhea Zambellas; Cushla Cooper; Ines Rombach; A Sarah Walker; Benjamin A Lipsky; Andrew Briggs; Andrew Seaton; Bridget Atkins; Andrew Woodhouse; Anthony Berendt; Ivor Byren; Brian Angus; Hemant Pandit; David Stubbs; Martin McNally; Guy Thwaites; Philip Bejon Journal: Trials Date: 2015-12-21 Impact factor: 2.279